Deutsche Biotech Innovativ AG

DUSE:DBI Stock Report

Market Cap: €1.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Deutsche Biotech Innovativ Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Bernd Wegener

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Feb 17
What Kind Of Investors Own Most Of Deutsche Biotech Innovativ AG (DUSE:DBI)?

Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

Dec 02
Deutsche Biotech Innovativ (DUSE:DBI) Is In A Good Position To Deliver On Growth Plans

CEO

Bernd Wegener (77 yo)

no data

Tenure

Dr. Bernd Wegener, FRICS, serves as the Chairman of Management Board and Chief Executive Officer at Deutsche Biotech Innovativ AG. Dr. Wegener served as Chairman of the Supervisory Board of Adrenomed AG un...